The single-use downstream bioprocessing market presents opportunities through enhanced operational flexibility, reduced downtime, and sustainability. Key drivers include the demand for efficient ...
Like all areas of bioprocessing, downstream purification has its own favored buzzwords—titers, bottlenecks, capacity, and others—meant to evoke a particular response depending on who is speaking or ...
Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results